Corindus Vascular Robotics, which as its name implies develops precision vascular robotics, was awarded “2013 Innovative Technology of the Year for Robotics” last week at the 16th annual Massachusetts Technology Leadership Council awards gala. The annual technology awards are meant to highlight the strength of the Massachusetts tech ecosystem and were attended this year by more than 700 senior executives, according to the event’s producers.
The Corindus CorPath System is designed to enable precise control of coronary guidewires and stent devices from the safety of a radiation-protected cockpit. According to MassTLC, it’s the first and only FDA-cleared technology for precise, robotic-assisted angioplasties and is used to open blockages within arteries and restore blood flow in patients with coronary artery disease.
“Using robotics to set new standards of safety, precision and accuracy will greatly benefit patients of medical procedures, such as angioplasties,” David Handler, president and CEO of Corindus, said in a statement about the award. “We are working diligently every day to deliver a future where better outcomes in healthcare go hand-in-hand with innovation and are proud to have our robotics recognized by MassTLC as we continue with our mission.”
The 2013 MassTLC Leadership Awards were sponsored by platinum sponsors Cisco, Greenberg Traurig, Microsoft, pwc and Silicon Valley Bank with additional support from gold sponsors Aericon, The Boston Globe, CA Technologies, KSquare Law, PTC, Raytheon and Sonus.
See all the 2013 winners at masstlc.org.
[ photo courtesy of Massachusetts Technology Leadership Council ]